Clinical Trial Update: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating QLS12010 capsules in adults with moderate-to-severe atopic dermatitis is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QLS12010 Capsules

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING